TCM

Tybourne Capital Management Portfolio holdings

AUM $34.5M
This Quarter Return
-3.14%
1 Year Return
-2.7%
3 Year Return
+56.17%
5 Year Return
+67.69%
10 Year Return
+491.48%
AUM
$1.04B
AUM Growth
+$1.04B
Cap. Flow
-$286M
Cap. Flow %
-27.45%
Top 10 Hldgs %
63.51%
Holding
27
New
Increased
2
Reduced
23
Closed
1

Top Buys

1
NVDA icon
NVIDIA
NVDA
$24.3M
2
LRCX icon
Lam Research
LRCX
$8.64M

Sector Composition

1 Technology 36.3%
2 Consumer Discretionary 22.8%
3 Financials 13.18%
4 Healthcare 8.96%
5 Industrials 7.82%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
TSHA icon
26
Taysha Gene Therapies
TSHA
$797M
$965K 0.09%
500,000
AMLX icon
27
Amylyx Pharmaceuticals
AMLX
$836M
-768,603
Closed -$14.8M